Madrid, Spain

Jésus Pérez-Gil

This inventor holds 1 USPTO granted patent. Top assignees: Universidad Complutense De Madrid, University of Ghent. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jésus Pérez-Gil. Retrieved from https://idiyas.com/inventor/jésus-pérez-gil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jésus Pérez-Gil

Introduction

Jésus Pérez-Gil is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of micro- and nanoparticles, particularly through his innovative work involving surfactant proteins and lipids. His research has implications for medical applications, especially in the treatment of various disorders.

Latest Patents

Jésus Pérez-Gil holds a patent for "Particles comprising surfactant protein B and one or more lipids." This invention focuses on coated nanoparticles that utilize surfactant protein B (SP-B) combined with lipids. The patent outlines the use of these coated particles and compositions as medicaments, particularly for delivering agents like small interfering RNA (siRNA) to target tissues or cells.

Career Highlights

Throughout his career, Jésus Pérez-Gil has worked with esteemed institutions such as Universiteit Gent and Universidad Complutense De Madrid. His research has been pivotal in advancing the understanding of nanoparticle applications in medicine.

Collaborations

Jésus has collaborated with notable colleagues, including Koen Raemdonck and Stefaan De Smedt. Their joint efforts have contributed to the development of innovative solutions in the field of nanomedicine.

Conclusion

Jésus Pérez-Gil's work exemplifies the intersection of innovation and medical science. His contributions to nanoparticle technology are paving the way for new treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…